HFpEF in hypertrophic cardiomyopathy predicts adverse outcomes. Discover how machine learning improves risk assessment.
Final random-forest-based models outperformed all publicly available risk scores on internal and external test sets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results